Skip to main content
Elizabeth Neil, MD, Neurology, Minneapolis, MN

ElizabethCatherineNeilMD

Neurology Minneapolis, MN

Neurooncology

Assistant Professor of Neurology

Dr. Neil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Neil's full profile

Already have an account?

  • Office

    University of Minnesota - Department of Neurology
    516 Delaware St SE 12-100 Phillips Wangensteen Building
    Minneapolis, MN 55455
    Phone+1 612-625-9900
    Fax+1 612-625-7950

Summary

  • Dr. Elizabeth C. Neil is a neuro-oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including the University of Minnesota Medical Center and M Health Fairview Southdale Hospital. She received her medical degree from Wayne State University School of Medicine and has been in practice 7 years. She specializes in neurooncology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2014 - 2016
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 2010 - 2014
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2010

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2016 - 2025
  • NY State Medical License
    NY State Medical License 2014 - 2017
  • OH State Medical License
    OH State Medical License 2010 - 2014
  • American Board of Psychiatry and Neurology Neurology
  • United Council for Neurologic SubspecialtiesNeuro-oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials
    New Treatment for Central Nervous System Tumors Enters Phase I Clinical TrialsJanuary 12th, 2021